• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/14

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

14 Cards in this Set

  • Front
  • Back
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Definition
Non cardiac pulmonary edema
Progressive refractory hypoxemia
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Complication of hospitalized patients
Serious medical-surgical problem
May not be lung related
Mortality remains 50-60%
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Characteristics
Refractory Hypoxemia
Decreased Pulmonary Compliance
Dyspnea
Non cardiac bilateral pulmonary edema
Dense pulmonary infiltrates with glass-ground appearance on CXR.
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
Pathophysiology
Injury or inflammation causes lung damage
Alveolar capillary membrane leaks
Plasma and blood cells into interstitial space
Interstitial pressure increases and fluid floods the alveoli
Surfactant inactivated
Coating forms over alveolar membrane
Etiology
No single exogenous or endogenous precipitating factor multiple causes.
Exact causative mechanism is unknown
Direct and Indirect Causes
Direct Lung Injury
Aspiration of gastric contents
Severe thoracic trauma
Pulmonary contusion
Diffuse pulmonary infection
Bacterial
Viral
Fungal: Pneumocystis carini
Toxic gas (smoke inhalation)
Near drowning
Indirect Lung Injury
Severe sepsis
Shock
Acute pancreatitis
Severe nonthoracic trauma
Multiple long bone fractures
Drug overdose
Hypertransfusion (multiple transfusions)
Reperfusion injury
After lung transplant
After cardiopulmonary bypass
Phases of ARDS
Phase I- Acute injury
Phase II- Latent period
Phase III- Exudative phase
Phase IV- Fibroproliferative phase
Clinical manifestations (Phase I)
Change in personality, disorientation, anxiety
Initial dyspnea w/ hyperventilation
Grunting respirations
Cyanosis, pallor
Retractions, use of accessory muscles
Dry cough
Diaphoresis
Lungs sounds initially clear
Crackles and rhonchi later
Vitals Signs
Fever
Hypotension
Tachycardia (dysrhythmias)
Refractory hypoxia
Phase II-III (Diagnostic Studies)
CXR -Diffuse, bilateral infiltrates

ABGs (Initial)
Hypoxemia
Respiratory alkalosis
Later
respiratory acidosis
hypoxia, hypercapnia
Medical management (Phase III)
Ventilator
FIO2
IMV
PEEP
Fluid control
Swan Ganz catheter
Measurement of pulmonary artery pressure (fluid)
Collaborative Management
Drugs and Fluids
Corticosteroids (inflammation)
Antibiotics (infection)
Modify inflammatory response-Vit C and E, N-acetylcysteine, nitric oxide, surfactant replacement
Optimal fluid therapy- titrate to maintain CO and tissue perfusion
May need diuretics decrease lung edema but avoid hypotension and dehydration
Red blood cells- transfusion if needed
Positioning
HOB elevated
Rotation
Prone
Nutrition
Enteral (tube feeding) nutrition or parenteral (TPN) nutrition started ASAP
Electrolyte replacement
Interventions
Assess
Sputum production
Oxygenation
Heart sounds
Lung sounds
Hemodynamic status
• Cardiac output
• Urinary output
Cardiac rhythm
Monitor
ABGs
Pulse oximetry
Ventilator settings
Fluid maintenance
Teach
Ventilator
Lines
Psychosocial Support
Phase IV
Multi-system failure
Heart failure
Acute renal failure
Acidosis
Sepsis
GI Bleed
DIC
Survival- vent dependent